671P Postoperative chemoradiation in combination with cetuximab followed by 6-months cetuximab maintenance in squamous cell carcinoma of the head and neck with high risk of locoregional recurrence

Autor: Tamaskovics, B.F., Matuschek, C., Haussmann, J., Debus, J., Held, T., Henke, M., Kirste, S., Bamberg, M., Stefan, W., Belka, C., Ganswindt, U., Wiegel, T., Mäurer, M., Budach, V., Stuschke, M., Schipper, J., Boelke, E., Budach, W.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S849-S849
Databáze: ScienceDirect